Piper Reynolds, BS, Director Healthcare Provider Engagement, National Multiple Sclerosis Society, New York, NY, Gloria von Geldern, MD, Neurology, University of Washington, Seattle, WA, Lucas McCarthy, MD, MS, Virginia Mason, Seattle, WA, Annette Wundes, MD, University of Washington, Seattle, WA, Jodie K Haselkorn, MD, MPH, Department of Epidemiology, University of Washington, Seattle, WA, Angeli Mayadev, MD, MS Center, Swedish Medical Center, Seattle, WA, Stacy Donlon, MD, MultiCare Neuroscience, Tacoma, WA, Kathleen Burgess, MD, VA MS Center of Excellence-West, Seattle, WA and Lynda R Hillman, DNP, MS Center of Excellence, West, VA Puget Sound Healthcare, Seattle, WA

Renee Stewart, DNP, APRN-NP1, Rana K. Zabad, MD2, Kristen Bayly, BSN1, Aubrie L Lindner, AA3, Kathleen Healey, NP, PhD4 and Mohamed Darwish, MD5, (1)Neurological Sciences, Nebraska Medicine, Omaha, NE, (2)NEUROLOGICAL SCIENCES, UNIVERSITY OF NEBRASKA MEDICAL CENTER, OMAHA, NE, (3)Neurological Sciences Program Operations Manager, Nebraska Medicine, Omaha, NE, (4)Neurologial Sciences, University of Nebraska, Omaha, NE, (5)Department of Neurology, University Nebraska Medical Center, Omaha, NE

Stacy Tyrrell, PharmD, BCACP1, Shannon Panther, PharmD, BCACP2, Aimie Inthoulay, BA3 and Jason Chau, PharmD, MSCS, BCPS, BCACP3, (1)Kaiser Permanente, Tacoma, WA, (2)Kaiser Permanente, Spokane, WA, (3)Kaiser Permanente, Renton, WA

Alexa Stuifbergen, PhD, RN, FAAN, Nico Osier, PhD, RN, Sungju M Lim, MSN, Heather Becker, PhD, Research Scientist and Eliana Gill, BSN, School of Nursing, The University of Texas at Austin, Austin, TX

Olivia Kaczmarek, BS1, Avtej Sethi, MS2, Gina Koch, Student2, Barbara Bumstead, MS, ANCP, MSCN2, Marijean Buhse, NP-C, PhD1, Myassar Zarif, MD1, Jeffrey Wilken, PhD3, Daniel Golan, MD4 and Mark Gudesblatt, MD5, (1)South Shore Neurologic Associates, Patchogue, NY, (2)South Shore Neurologic Associates, P.C., Patchogue, NY, (3)Washington Neuropsychology Research Group, Washington, DC, (4)Rapparport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel, (5)South Shore Neurologic Associates, P.C., Islip, NY

Elizabeth S Gromisch, PhD1,2,3, Aaron P Turner, Ph.D. ABPP (RP)4,5,6, Lindsay O Neto, MPH1,7, Jennifer A. Ruiz, DPT1,3, Albert C. Lo, MD, PhD1, Thomas P Agresta, MD, MBI8,9 and Frederick W Foley, Ph.D.10,11, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (7)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (8)Department of Family Medicine, University of Connecticut Health Center, Farmington, CT, (9)Center for Quantitative Medicine, University of Connecticut Health Center, Farmington, CT, (10)Holy Name Medical Center, Teaneck, NJ, (11)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY

Elizabeth S Gromisch, PhD1,2,3, Jodie K Haselkorn, MD, MPH4,5,6,7, Sarah A Raskin, PhD8,9, Lindsay O Neto, MPH1,10 and Aaron P Turner, Ph.D. ABPP (RP)4,5,7, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (5)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (6)Department of Epidemiology, University of Washington, Seattle, WA, (7)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (8)Neuroscience Program, Trinity College, Hartford, CT, (9)Department of Psychology, Trinity College, Hartford, CT, (10)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT

Erica Weber, PhD, Anthony Lequerica, PhD and Lauren B Strober, Ph.D., Kessler Foundation, East Hanover, NJ

Joelle Massouh, MSN, MSCN, Beirut, Lebanon

Nina Rose, MA, Clinical Health Psychology PhD, Ferkauf Graduate School of Professional Psychology, Brooklyn Heights, NY

Odessa J. McKenna, MSc1,2, Afolasade Fakolade, PhD3, Katherine L. Cardwell, BHSc1 and Lara A. Pilutti, PhD1,4, (1)Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada, (2)Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada, (3)School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, (4)Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada

Babita Bisht, PT, PhD1, Tyler J. Titcomb, PhD, RDN1, Warren G Darling, PhD2, Lucas J Carr, PhD2, Karin F. Hoth, PhD3, Patrick Ten Eyck, PhD4, Linda Rubenstein, PhD5, John A Kamholz, MD, PhD6, Linda G. Snetselaar, PhD, RDN5 and Terry L. Wahls, MD1, (1)Department of Internal Medicine, University of Iowa, Iowa City, IA, (2)Department of Health and Human Physiology, University of Iowa, Iowa City, IA, (3)Department of Psychiatry, University of Iowa, Iowa City, IA, (4)Institute for Clinical and Translational Science, University of Iowa, Iowa City, IA, (5)Department of Epidemiology, University of Iowa, Iowa City, IA, (6)Neurology, University of Iowa, Iowa City, IA

Dinika Anand, Masters, New Delhi, India, Soumi Awasthy, PhD, Defence Institute of Psychological Research, New Delhi, India and Rajiv Anand, MD, Dr. B.L.Kapoor Superspeciality Hospital, New Delhi, India

Jagriti ‘Jackie’ Bhattarai, PhD, MS, Physical Medicine and Rehabilitation, Johns Hopkins School of Medicine, Baltimore, MD

Zain Awadia, BHSc, Faculty of Health Sciences, University of Ottawa, Ottawa, ON, Canada, Thomas Edwards, MSc, School of Human Kinetics, University of Ottawa, Ottawa, ON, Canada, Jason A Berard, PhD, Neuroscience, Ottawa Hosptial Research Institute, Ottawa, ON, Canada, Lisa A.S. Walker, Ph.D., The Ottawa Hospital Research Institute, Ottawa, ON, Canada and Lara A. Pilutti, PhD, Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada

Afiah Hasnie, Psy.D., Neurology, Cleveland Clinic Mellen Center for MS, Cleveland, OH

Alexander J. Keenan, MA, MHP1, Tatiana Scherz, MD2, Brian Hennessy, PhD2, Hilke Kracker, PhD2 and Janssen R&D, (1)Janssen Research & Development, Titusville, NJ, (2)Janssen R&D, Allschwil, Switzerland

Amir Khakban, Msc., Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, Elisabet Rodriguez Llorian, PhD, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, Scott B Patten, MD, PhD, Community Health Sciences & Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada, Anthony L. Traboulsee, MD, Neurology, The University of British Columbia, Vancouver, BC, Canada and Larry Lynd, PhD, . Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada

Avtej Sethi, MS1, Olivia Kaczmarek, BS2, Jack Petroski, Student1, Emma Malone, Student1, Barbara Bumstead, MS, ANCP, MSCN1, Marijean Buhse, NP-C, PhD2, Myassar Zarif, MD2, Daniel Golan, MD3, Jeffrey Wilken, PhD4 and Mark Gudesblatt, MD5, (1)South Shore Neurologic Associates, P.C., Patchogue, NY, (2)South Shore Neurologic Associates, Patchogue, NY, (3)Rapparport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel, (4)Washington Neuropsychology Research Group, Washington, DC, (5)South Shore Neurologic Associates, P.C., Islip, NY

Beth Schneider, Senior Research Director, MyHealthTeams, San Francisco, CA

Barry Hendin, MD, Phoenix Neurological Associates, Phoenix, AZ; Neurology, University of Arizona, Tucson, AZ, Richard A. Brook, MS, MBA, Better Health Worldwide, Inc., Newfoundland, NJ, Ian A. Beren, BS, WorkPartners, LLC, Loveland, CO, Nathan L. Kleinman, PhD, WorkPartners, LLC, Cheyenne, WY, Amy L. Phillips, PharmD, EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany, Rockland, MA and Carroline Lobo, PhD, EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, MA, Germany

Barry Hendin, MD, Neurology, University of Arizona, Tucson, AZ, Richard A. Brook, MS, MBA, Better Health Worldwide, Inc., Newfoundland, NJ, Ian A. Beren, BS, WorkPartners, LLC, Loveland, CO, Nathan L. Kleinman, PhD, WorkPartners, LLC, Cheyenne, WY, Cindy Fink, BSc, Care Partner Adviser, Cleveland Heights, OH, Amy L. Phillips, PharmD, EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany, Rockland, MA and Carroline Lobo, PhD, EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, MA, Germany

Craig Riccardo, PharmD, CSP, MSCS and Kate Jelline, PharmD, MSCS, CSP, Ardon Health, Portland, OR

Crystal Watson, MS1, Kayla Scippa, BA2, Arie Barlev, PharmD1 and Jason C Cole, PhD2, (1)Atara Biotherapuetics, South San Francisco, CA, (2)ZS Associates, Thousand Oaks, CA

Danielle Bryan, PharmD1, Rebekah Finley, PharmD candidate2, Autumn Zuckerman, PharmD, BCPS, AAHIVP, CSP1, Megan Peter, PhD1, Ryan Moore, MS3 and Leena Choi, PhD3, (1)Vanderbilt Specialty Pharmacy, Vanderbilt University Medical Center, Nashville, TN, (2)Lipscomb University, Nashville, TN, (3)Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN

Eleanor Bryan, M.Ed1, Falguni Mehta, MS, MBA1 and Brant J. Oliver, PhD, MS, MPH, APRN-BC2, (1)Department of Community & Family Medicine, Dartmouth Hitchcock Health, Lebanon, NH, (2)Geisel School of Medicine at Dartmouth, Lebanon, NH

Erin M Faraclas, PT, DPT, PhD(c), MSCS, Doctor of Philosophy in Health Sciences Program, Rocky Mountain University, Provo, UT; School of Physical Therapy, MCPHS, Worcester, MA, Angela Merlo, PT, DPT, PhD, Department of Physical Therapy, Eastern Washington University, Spokane, WA, Jeffery Lau, PT, DPT, PhD, College of Rehabilitation Sciences, Rocky Mountain University, Provo, UT and Jeff Lynn, PhD, Slippery Rock University, Slippery Rock, PA

Farren B.S. Briggs, PhD, ScM1, Nina Bozinov, MD, MS2, Robert N. McBurney, PhD3, Hollie Schmidt, MS4, Laura Kolaczkowski, BA3 and Sara Loud, MSEE, MBA4, (1)Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, (2)Neurology, Kootenai Clinic, Coeur d’Alene, ID, (3)Accelerated Cure Project for MS, Waltham, MA, (4)Accelerated Cure Project for Multiple Sclerosis, Waltham, MA

Heather M DelMastro, MSc1,2, Jennifer A. Ruiz, DPT1,3 and Elizabeth S Gromisch, PhD1,3,4, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT

Jennifer S. Harper, PhD, MS1, Nayad T. Manukian, MS1, David M. Kern, PhD2, Smita Mitra, PhD1, Alex Z. Fu, PhD, MS3, Hoa H. Le, PhD4, Allitia DiBernardo, MD1 and John J. Sheehan, Phd, RPh3, (1)Janssen Pharmaceuticals, Inc., Titusville, NJ, (2)Janssen Research & Development, LLC, Titusville, NJ, (3)Janssen Scientific Affairs, LLC, Titusville, NJ, (4)Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, NJ

Elaine Rudell, CHCP1, Tarjani Agrawal, PhD1, Patty Peterson, BS2, Andrea L. Griffin, BS3, Michele Fallon Ingram, BS1 and James Bowen, MD4, (1)@Point of Care, Short Hills, NJ, (2)Projects In Knowledge, Short Hills, NJ, (3)Multiple Sclerosis Association of America, Cherry Hill, NJ, (4)Swedish Neuroscience Institute, Seattle, WA

Joan Augustyn, OTD, OTR/L, McKara Shaw, OTS, Anna Watkins, OTS, Madeline Mason, OTS and Justina Bayless, OTS, Occupational Therapy Education and MS Achievement Center, University of Kansas Medical Center, Kansas City, KS

Kathleen Costello, MS, CRNP, MSCN, Programs, Can Do Multiple Sclerosis, Avon, CO

Lindsay O Neto, MPH1,2, Jennifer A. Ruiz, DPT1,3 and Elizabeth S Gromisch, PhD1,3,4, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT

Matthew Molaei, PharmD1, Anna Chen, PharmD1, Anna Vaeth, BS2, Karen Walsh, MS, MBA1 and Brant J. Oliver, PhD, MS, MPH, APRN-BC3, (1)College of Population Health, Thomas Jefferson University, Philadelphia, PA, (2)Multiple Sclerosis Imaging Center, Dept. of Neurology, Massachusetts General Hospital; Harvard Medical School, Charlestown, MA, (3)Geisel School of Medicine at Dartmouth, Lebanon, NH

Alex Keenan, MS1, Hoa Le, PhD2, Christopher Pelligra, PhD3, Ibrahim Turkoz, PhD4, Shien Guo, PhD5, Weiqin Liao, PhD5 and Michele Cole, PharmD, MS1, (1)Research and Development, Janssen Pharmaceuticals, Titusville, NJ, (2)Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ, (3)Evidence Synthesis, Modeling and Communication, Evidera, Bethesda, MD, (4)Janssen Research & Development, Titusville, NJ, (5)Evidence, Value and Access, Evidera, Bethesda, MD

Michele Cole, PharmD, MS1, Alexander J. Keenan, MA, MHP2, Hoa Le, PhD3, Christopher Pelligra, PhD4, Shien Guo, PhD5 and Weiqin Liao, PhD5, (1)Research and Development, Janssen Pharmaceuticals, Titusville, NJ, (2)Janssen Research & Development, Titusville, NJ, (3)Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ, (4)Evidence Synthesis, Modeling and Communication, Evidera, Bethesda, MD, (5)Evidence, Value and Access, Evidera, Bethesda, MD

Nananda Col, MD, MPH., MPP, FACP1, Christina Fitzpatrick, MA1, Enrique Alvarez, MD2, Lori Pbert, PhD3, Carolina Ionete, MD, PhD4, Idanis Berrios Morales, MD5, Andrew J. Solomon, MD6, Christen Kutz, PhD, PA-C7, Terrie Livingston, PharmD8, Jennifer Chester, FNP-BC, MSCN9, Crystal Iwuchukwu, RN, BSN, FNP10 and Long Ngo, MD11, (1)Shared Decision Making Resources, Georgetown, ME, (2)University of Colorado, Denver, CO, (3)University of Massachusetts Medical School, Worcester, MA, (4)University of Massachusetts Memorial Medical Center, Worcester, MA, (5)University of Massachusetts Medical Center, Worcester, MA, (6)Neurological Sciences, Larner College of Medicine at the University of Vermont, Burlington, VT, (7)Colorado Springs Neurological Associates, Colorado Springs, CO, (8)EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, MA, Germany, (9)Kansas City MS Center at College Park Specialty, Overland Park, KS, (10)Southeast Health, Cape Girardeau, MO, (11)Beth Israel Deaconess Medical Center, Boston, MA

Nina Bozinov, MD, MS, Neurology, Kootenai Clinic, Coeur d’Alene, ID and Farren B.S. Briggs, PhD, ScM, Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH